Product Discontinuation Notice

Dear Customer,

after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.

While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.

Who we are

QIAGEN Lake Constance GmbH changed its name and branding in September 2020 to DIALUNOX GmbH.

QIAGEN Lake Constance came into existence in July 2010 when Embedded System Engineering (ESE) GmbH changed its name after joining the QIAGEN family. Originally a spin off from Perkin Elmer Bodenseewerk, the privately owned ESE GmbH was founded in 1997.

DIALUNOX is a center of excellence for optical detection and point-of-need instrumentation. We focus on the development and production of portable instruments for point-of-need testing. Our easy to use original equipment manufacturer (OEM) products enable our customers to develop their final product, either a lateral flow technology or a nucleic acid-based / isothermal amplification assays device. These rapid test devices have countless different applications, from food and feed safety testing to veterinary analysis, and many more.

We work according to Quality Management ISO 9001 and ISO 13485 standards and are an FDA-registered contract manufacturer.

Our vision is to improve quality of life by being the leading system provider for decentralized Life Sciences and In Vitro Diagnostics testing.

We work where other people are spending their holidays.

What we do

Our company offers a broad portfolio of products and services such as:

Contact our sales team to find out more about our key business areas in rapid testing.


QIAGEN offers a broad range of more than 500 core products to meet the special requirements of over 500,000 customers worldwide.

QIAGEN has also developed complete instrument solutions to enable full automation of laboratory procedures, from the initial sample to the final result.

For more information about QIAGEN

QIAGEN in Hilden, Germany


QIAGEN’s broad range of consumables includes complete kits for predefined applications in sample preparation and analysis as well as individual enzymes and reagents that research laboratories can use to develop their own protocols and applications.


QIAGEN offers more than 15 dedicated instruments for automating a full range of laboratory procedures, from initial sample preparation to the final test result.

QIAGEN’s product range also s includes other devices for specialized laboratory applications such as point of need tests.

Detection technologies

QIAGEN is a firm believer in providing appropriate solutions for different problems. This is why we offers a range of innovative technologies that make the latest advances in molecular biology accessible to an ever larger number of users.

As of September 30, 2015, QIAGEN employed approximately 4,500 people in over 35 locations worldwide.